Home / Inspections / 1014180

FDA Inspection 1014180 — Northwestern Medicine

Northwestern Medicine — FEI 3004743924

The FDA completed an inspection of Northwestern Medicine on May 31, 2017 in Chicago, IL. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
May 31, 2017
Fiscal Year
2017
Product Type
Biologics
Project Area
Human Cellular, Tissue, and Gene Therapies
Location
Chicago, IL (United States)

Facility

Other inspections at this facility

  • 1265805 (NAI Wed Apr 02 2025 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1121895 (NAI Wed Feb 26 2020 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 918294 (NAI Sat Mar 07 2015 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 833833 (NAI Tue Jun 04 2013 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 703407 (NAI Wed Dec 22 2010 00:00:00 GMT+0000 (Coordinated Universal Time))

FDA data resources